NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
Clinical Trials
8 trialsNCT02567799 2024-01-25
NSCLC
Humanetics Corporation
Phase 1/2 Completed
NCT00244933 2023-06-22
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00118040 2021-06-10
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00376948 2021-03-01
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT01985763 2019-05-10
Genistein in Treatment of Metastatic Colorectal Cancer
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT00290758 2017-02-08
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01325311 2016-08-03
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed